Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply.

Kokkotis, Georgios; Kitsou, Konstantina; Bamias, Giorgos

Kokkotis, Georgios; Kitsou, Konstantina; Bamias, Giorgos.

Afiliação

Kokkotis G; GI Unit, 3rd Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Kitsou K; Immunobiology and Vaccinology Research Lab, First Department of Paediatrics, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Bamias G; GI Unit, 3rd Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Aliment Pharmacol Ther ; 55(9): 1235-1236, 2022 05.

Article em En | MEDLINE | ID: mdl-35429035

Assuntos

COVID-19; Doença de Crohn; Doenças Inflamatórias Intestinais; Humanos; Inibidores do Fator de Necrose Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doença de Crohn / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google